Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Tarlatamab's trials
RAGNAR
Refractory Advanced diGestive Neuroendocrine Carcinomas Treated With tARlatamab
Tarlatamab
Ongoing
Recruiting
Phase 2
Open NCT07061080 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
RAGNAR · Trial Tracker · ComplyRx
